NasdaqGS - Nasdaq Real Time Price USD
Taysha Gene Therapies, Inc. (TSHA)
2.7900
+0.0100
+(0.36%)
At close: June 4 at 4:00:00 PM EDT
2.8700
+0.08
+(2.87%)
After hours: June 4 at 7:58:36 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -0.09 | -0.09 | -0.31 | -0.41 |
| Low Estimate | -0.09 | -0.09 | -0.36 | -0.55 |
| High Estimate | -0.09 | -0.08 | -0.27 | -0.27 |
| Year Ago EPS | -0.09 | -0.07 | -0.36 | -0.31 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 11 |
| Avg. Estimate | 1.6M | 1.56M | 7.14M | 4.94M |
| Low Estimate | -- | -- | 2.3M | -- |
| High Estimate | 3.8M | 3.8M | 15M | 15M |
| Year Ago Sales | 1.11M | 1.79M | 8.33M | 7.14M |
| Sales Growth (year/est) | 44.33% | -12.53% | -14.26% | -30.90% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.1 | -0.09 | -0.08 | -0.09 |
| EPS Actual | -0.09 | -0.07 | -0.07 | -0.07 |
| Difference | 0.01 | 0.02 | 0.01 | 0.02 |
| Surprise % | 14.80% | 20.89% | 15.39% | 17.07% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.09 | -0.31 | -0.41 |
| 7 Days Ago | -0.09 | -0.09 | -0.31 | -0.34 |
| 30 Days Ago | -0.09 | -0.09 | -0.37 | -0.39 |
| 60 Days Ago | -0.09 | -0.09 | -0.38 | -0.41 |
| 90 Days Ago | -0.09 | -0.09 | -0.38 | -0.41 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 1 |
| Up Last 30 Days | 1 | 1 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TSHA | -5.63% | -19.38% | 11.96% | -31.92% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 6/3/2025 |
| Reiterates | Needham: Buy to Buy | 6/2/2025 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 5/29/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/29/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/16/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 4/28/2025 |
Related Tickers
ORIC ORIC Pharmaceuticals, Inc.
9.08
+8.10%
TRVI Trevi Therapeutics, Inc.
6.58
+10.59%
TNGX Tango Therapeutics, Inc.
3.2700
+0.93%
ANAB AnaptysBio, Inc.
21.27
-9.57%
NGNE Neurogene Inc.
21.67
+5.40%
ITOS iTeos Therapeutics, Inc.
10.20
+0.99%
LXEO Lexeo Therapeutics, Inc.
3.1000
+9.93%
BCAX Bicara Therapeutics Inc.
11.16
+1.36%
QURE uniQure N.V.
14.96
-1.32%
COGT Cogent Biosciences, Inc.
5.64
-2.59%